Synthetic 45S5 Bioactive Glass: ISO-Certified Manufacturer 

Synthetic 45S5 Bioactive Glass is a specific formulation of melt-derived bioactive glass, originally developed by Larry Hench, characterized by its ability to bond directly with living bone and soft tissue. This material contains 45% SiO₂, 24.5% Na₂O, 24.5% CaO, and 6% P₂O₅ by weight. It is the gold standard for bone regeneration applications, including dental alveolar ridge preservation, orthopedic void fillers, and wound care dressings. High-purity synthetic 45S5 granules, powders, and scaffolds that meet strict medical device standards (ISO 13485) are essential for these applications. Our manufacturing partners ensure consistent particle size distribution, sterile packaging, and reproducible bioactivity, making this material the preferred choice for B2B medical device companies and research institutions requiring reliable raw materials for regenerative medicine.

What is Synthetic 45S5 Bioactive Glass?

Bioactive glass 45S5 represents a unique class of biomaterials that interact physiologically with the host environment. Unlike inert implants such as titanium or polyethylene, which form a fibrous capsule to isolate themselves from the body, 45S5 bioactive glass forms a strong chemical bond with bone. The term “45S5” refers to its composition: 45 weight percent silica (SiO₂) and a 5:1 molar ratio of calcium to phosphorus. This specific stoichiometry is critical for triggering the biological response required for osteoconduction and osteostimulation.

The “synthetic” designation distinguishes this product from natural mineral derivatives. It is produced through a controlled melt-quenching process, ensuring high purity and the absence of biological contaminants. This synthetic origin is crucial for regulatory compliance in medical markets, where traceability and consistency are paramount. For manufacturers of bone graft substitutes, having a reliable source of ISO-certified 45S5 raw material is the foundation of product safety and efficacy.

The Historical Significance and Composition

Discovered in 1969, 45S5 was the first material demonstrated to bond to bone. Its composition lies within a narrow window of the ternary system SiO₂-Na₂O-CaO-P₂O₅. Deviating from this precise formula can result in a material that is either too soluble (dissolving before bone forms) or too stable (failing to release the ions necessary for gene activation). Manufacturing protocols strictly adhere to this original formulation while optimizing the physical form for modern surgical applications.

• Silica (SiO₂): Provides the structural network. At 45%, it allows for sufficient dissolution to release therapeutic ions without compromising structural integrity during the initial healing phase.
• Sodium Oxide (Na₂O): Acts as a network modifier, increasing the dissolution rate and facilitating ion exchange with body fluids.
• Calcium Oxide (CaO): Essential for hydroxyapatite formation, the mineral component of bone.
• Phosphorus Pentoxide (P₂O₅): Works in conjunction with calcium to precipitate a biologically active hydroxycarbonate apatite (HCA) layer.

How Does 45S5 Bioactive Glass Work? The Mechanism of Action

Understanding the mechanism of action is vital for engineers and product developers designing medical devices. The bioactivity of 45S5 is not passive; it is a dynamic, time-dependent sequence of chemical reactions that occur at the interface between the glass and physiological fluids. This process transforms the glass surface into a biologically active scaffold that supports cell attachment and proliferation.

Stage 1: Rapid Ion Exchange

Upon contact with body fluids, alkali ions (Na⁺ and K⁺) from the glass exchange with protons (H⁺) or hydronium ions (H₃O⁺) from the fluid. This rapid exchange leads to a localized increase in pH and the formation of silanol (Si-OH) groups on the glass surface. This step is critical because it prepares the surface for subsequent reactions and releases ions that have been shown to upregulate osteogenic genes in surrounding cells.

Stage 2: Hydrolysis of Silica Network

The loss of alkali ions destabilizes the silica network. Siloxane (Si-O-Si) bonds break, leading to the condensation of silanol groups into a porous silica-rich gel layer. This gel layer serves as a template for the next stage. The porosity of this layer allows for the infiltration of proteins and cells, facilitating integration with the host tissue.

Stage 3: Precipitation of Amorphous Calcium Phosphate

Calcium (Ca²⁺) and phosphate (PO₄³⁻) ions migrate from the bulk glass and the surrounding fluid to the surface. They accumulate on the silica-rich gel layer, forming an amorphous calcium phosphate film. This step is driven by the supersaturation of these ions in the immediate microenvironment created by the dissolving glass.

Stage 4: Crystallization into Hydroxycarbonate Apatite (HCA)

The amorphous calcium phosphate layer crystallizes into hydroxycarbonate apatite (HCA). HCA is chemically and structurally similar to the mineral phase of human bone. This HCA layer is the key to bonding. It provides a surface that bone-forming cells (osteoblasts) recognize as “self,” allowing them to attach, spread, and deposit new collagen and bone matrix. This results in a direct chemical bond between the implant and the bone, without any intervening fibrous tissue.

Quality Assurance and Supply Chain Integrity

In the medical device and aesthetic medicine industries, the quality of raw materials directly impacts patient safety, regulatory approval, and clinical outcomes. Ensuring the integrity of Synthetic 45S5 Bioactive Glass requires more than just manufacturing capability; it demands a robust, transparent, and scientifically rigorous supply chain.

Partnering with Jinan Meiyi Biotechnology

Jinan Meiyi Biotechnology Co., Ltd., headquartered in Jinan, Shandong Province, serves as a specialized provider of high-performance raw materials, acting as a trusted enabler for innovation across the global personal care and aesthetic medicine value chain. As a subsidiary of Pacific Kangtai Scientific Instruments (Jinan) Co., Ltd., the company is dedicated to the research, development support, and commercialization of bioactive technologies.

Unlike traditional manufacturers, Jinan Meiyi Biotechnology operates as a strategic sourcing and quality-assured distribution partner. The company does not engage in raw material manufacturing itself but leverages a well-established global supply chain network to maintain long-term cooperative relationships with internationally recognized, ISO-certified suppliers. This model ensures consistent access to technically advanced, regulatory-compliant, and scientifically validated materials like Synthetic 45S5 Bioactive Glass.

Rigorous Quality Control and Traceability

The bioactivity of 45S5 is highly sensitive to impurities. Trace amounts of heavy metals or inconsistent oxide ratios can inhibit bone growth or cause adverse tissue reactions. Jinan Meiyi Biotechnology’s quality assurance framework centers on supplier qualification, documentation traceability, and batch-level specification verification. All raw materials undergo comprehensive evaluation prior to inclusion in the portfolio, with selection criteria grounded in efficacy data, stability profiles, and compatibility with modern formulation standards.

Each batch of 45S5 bioactive glass is accompanied by full technical dossiers, including Certificates of Analysis (CoA), Material Safety Data Sheets (MSDS), and regulatory status summaries. Full traceability is maintained, allowing clients to track any finished product back to its specific raw material lots. This level of transparency reduces sourcing complexity for R&D laboratories, CDMOs, and aesthetic clinics, enabling them to maintain full confidence in material consistency and regulatory readiness.

Controlled Melt-Quenching Process at Source

The synthesis of 45S5 involves melting the raw oxides at high temperatures (typically above 1300°C) to ensure homogeneity. The molten glass is then quenched rapidly to prevent crystallization, resulting in an amorphous structure. Crystalline phases are undesirable as they alter the dissolution rate and bioactivity. Our partnered manufacturing facilities utilize tightly controlled thermal processing parameters with automated feedback systems to ensure every particle is truly amorphous.

Particle Size Engineering and Milling

Bioactive glass is rarely used as bulk monoliths in modern medicine. It is typically processed into particulates for injectables, putties, or coatings. Through our strategic partnerships, we offer precise milling and sieving services to achieve specific particle size distributions (PSD). Whether you require sub-micron powders for composite reinforcement or 300-800 µm granules for bone void filling, our PSD controls ensure consistent handling characteristics and clinical performance.

Key Properties and Technical Specifications

For R&D teams and procurement specialists, understanding the technical specifications of Synthetic 45S5 is essential for product design. The following table outlines the standard properties of our ISO-certified material. Custom specifications are available upon request for specialized applications.

Particle Size Options

The application dictates the required particle size. We provide a range of standard cuts:

• Sub-micron Powders (<1 µm): Used for reinforcing polymer composites, creating bioactive coatings via sol-gel or suspension methods, and enhancing the mechanical properties of cements.
• Fine Powders (1-10 µm): Ideal for injectable pastes and minimally invasive procedures where flowability is critical.
• Granules (100-300 µm): Commonly used in periodontal defects and small bone voids. Offers a balance between surface area and handling ease.
• Coarse Granules (300-800 µm): Preferred for larger orthopedic voids and alveolar ridge preservation. Provides structural support and space maintenance for bone ingrowth.

Clinical Applications of Synthetic 45S5 Bioactive Glass

The versatility of 45S5 bioactive glass has led to its adoption across multiple medical disciplines. Its ability to stimulate bone growth while resorbing over time makes it an ideal temporary scaffold for regeneration. Below are the primary sectors where our ISO-certified material is utilized.

Dentistry and Oral Surgery

In dentistry, 45S5 is widely used for alveolar ridge preservation, sinus lifts, and periodontal defect repair. After tooth extraction, the bone socket naturally resorbs. Filling the socket with 45S5 granules preserves the bone volume, facilitating future dental implant placement. The material’s hemostatic properties also help control bleeding during surgery, improving visibility and outcomes.

For periodontal disease, where bone supporting the teeth is lost, 45S5 promotes the regeneration of both bone and periodontal ligament. Its antibacterial effect, caused by the localized pH elevation and osmotic pressure during ion exchange, helps reduce bacterial load in the infected site, a unique advantage over synthetic polymers or allografts.

Orthopedics and Trauma Surgery

Orthopedic surgeons use 45S5 bioactive glass as a bone void filler in trauma cases, spinal fusion, and revision joint replacement. When bone is removed due to fracture or tumor resection, a void remains. 45S5 fills this void, providing immediate structural support while stimulating the body’s own healing mechanisms. Over time, the glass resorbs and is replaced by native bone, restoring the structural integrity of the skeleton.

In spinal fusion, 45S5 is often combined with autograft (patient’s own bone) or used as a standalone extender to reduce the amount of autograft needed. This reduces donor site morbidity and surgical time.

Wound Care and Dermatology

Beyond hard tissue, 45S5 has shown remarkable efficacy in soft tissue healing. Bioactive glass fibers and powders are incorporated into wound dressings for chronic ulcers, diabetic foot ulcers, and burns. The release of silicon and calcium ions stimulates fibroblasts and keratinocytes, accelerating the formation of granulation tissue and epithelialization. Furthermore, the material’s ability to absorb exudate and maintain a moist wound environment, combined with its inherent antibacterial activity, makes it highly effective for managing infected wounds.

Otolaryngology (ENT)

In ear, nose, and throat surgery, 45S5 is used for ossicular chain reconstruction and mastoidectomy obliteration. Its biocompatibility and stability in the middle ear environment make it a safe and effective material for reconstructing delicate auditory structures.

Advantages of Synthetic 45S5 Over Alternative Biomaterials

When selecting a biomaterial for bone regeneration, clinicians and manufacturers compare several options: autografts, allografts, xenografts, and synthetic substitutes. Synthetic 45S5 bioactive glass offers distinct advantages that address the limitations of other materials.

Comparison with Autografts (Gold Standard)

Autologous bone grafts (taken from the patient) are considered the gold standard due to their osteogenic, osteoinductive, and osteoconductive properties. However, harvesting autograft requires a second surgical site, leading to increased pain, risk of infection, and longer recovery times. There is also a limited supply of autograft. 45S5 bioactive glass eliminates the need for a second surgical site, is available in unlimited quantities, and provides consistent quality without donor variability.

Comparison with Allografts and Xenografts

Allografts (human donor bone) and xenografts (animal bone, usually bovine) carry risks of disease transmission and immune rejection, despite rigorous processing. They also raise ethical and religious concerns for some patients. Being synthetic, 45S5 is free from biological pathogens, eliminating the risk of disease transmission. It is ethically neutral and acceptable to all patient populations. Additionally, allografts and xenografts primarily act as passive scaffolds (osteoconductive), whereas 45S5 actively stimulates bone growth (osteostimulative).

Comparison with Other Synthetics (HA, TCP)

Hydroxyapatite (HA) and Beta-Tricalcium Phosphate (β-TCP) are common synthetic ceramics. While biocompatible, they are generally less bioactive than 45S5. HA is very stable and resorbs extremely slowly, sometimes persisting for years. β-TCP resorbs faster but lacks the ion-release profile that stimulates gene expression. 45S5 strikes a balance: it bonds faster than HA and provides therapeutic ion release that neither HA nor TCP can match. Its ability to bond to soft tissue is also unique among these ceramics.

Selection Guide: Choosing the Right 45S5 Product for Your Application

For B2B buyers and product developers, selecting the right form of 45S5 bioactive glass is critical for the success of the final medical device. Consider the following factors when specifying your requirements.

1. Determine the Clinical Indication

The intended use dictates the physical form. For injectable applications, such as minimally invasive spinal procedures or dental injections, a fine powder or small granule size is necessary to pass through needles or catheters. For open surgical procedures like ridge preservation, larger granules provide better space maintenance and handling.

2. Define the Resorption Profile

While the composition is fixed, the particle size and porosity influence the resorption rate. Smaller particles have a higher surface area-to-volume ratio and dissolve faster. If long-term volume stability is required, larger granules or composite forms may be preferred. Discuss your desired resorption timeline with our technical team to select the optimal PSD.

3. Sterility Requirements

Will the material be sterilized by the end-user, or do you require pre-sterilized product? We offer gamma irradiation and ethylene oxide (EtO) sterilization services, validated to achieve a Sterility Assurance Level (SAL) of 10⁻⁶. Pre-sterilized packaging reduces the burden on your manufacturing process and ensures readiness for cleanroom assembly.

4. Regulatory Support

As a partner committed to regulatory compliance, we provide comprehensive documentation packages, including Certificates of Analysis (CoA), Material Safety Data Sheets (MSDS), and Biocompatibility Test Reports (cytotoxicity, sensitization, irritation). These documents are essential for your regulatory filings. Ensure your supplier can provide full traceability and technical support throughout your product development lifecycle.

Common Mistakes in Handling and Processing Bioactive Glass

Even high-quality 45S5 bioactive glass can fail if not handled correctly. Avoid these common pitfalls to ensure optimal performance in your final product.

• Exposure to Moisture During Storage: Bioactive glass is hygroscopic. Exposure to humidity can initiate premature surface reactions, reducing its shelf life and bioactivity. Always store in airtight, desiccated containers. Our packaging includes moisture barriers and desiccants to prevent this.
• Contamination During Mixing: When compounding 45S5 with polymers or binders, ensure all equipment is clean and dry. Contaminants can interfere with the ion exchange process or introduce toxins.
• Incorrect Particle Size Selection: Using particles that are too large can lead to poor integration and encapsulation by fibrous tissue. Particles that are too small may resorb too quickly or be difficult to handle. Match the PSD to the specific anatomical defect.
• Ignoring pH Effects in Composites: The initial alkaline pH spike from 45S5 can affect certain pH-sensitive polymers. Formulators should account for this interaction when developing composite materials to prevent premature degradation of the polymer matrix.

Frequently Asked Questions (FAQ)

Is Synthetic 45S5 Bioactive Glass safe for human use?

Yes, 45S5 bioactive glass has a extensive clinical history spanning over three decades. It is biocompatible, non-toxic, and non-carcinogenic. Our ISO-certified supply chain ensures that the material meets strict safety standards, including cytotoxicity and sensitization testing. It is approved for various medical applications globally.

How long does it take for 45S5 to bond with bone?

The formation of the hydroxycarbonate apatite (HCA) layer begins within minutes to hours after implantation. Strong chemical bonding with bone typically occurs within days to weeks, depending on the local biological environment. Complete resorption and replacement by native bone can take several months, providing a gradual transfer of load to the new tissue.

Can 45S5 bioactive glass be used in infected sites?

Yes, one of the unique advantages of 45S5 is its antibacterial property. The localized increase in pH and osmotic pressure during the initial ion exchange phase creates an environment that is hostile to many bacteria. This makes it particularly useful in periodontal therapy and wound care where infection risk is high.

What is the shelf life of Synthetic 45S5 Bioactive Glass?

When stored in its original, unopened, moisture-proof packaging at room temperature, the shelf life is typically 3 to 5 years. Proper storage is critical to maintain bioactivity. Once opened, the material should be used immediately or stored in a dry, inert atmosphere.

Do you provide custom particle sizes?

Yes, through our specialized manufacturing partners, we offer custom milling and sieving services. We can tailor the particle size distribution to meet the specific requirements of your device design, whether you need nano-powders for coatings or specific granule cuts for grafts.

How does 45S5 compare to S53P4 bioactive glass?

Both are bioactive glasses, but they have different compositions. 45S5 has higher silica content and no magnesium, while S53P4 contains magnesium and less silica. 45S5 is generally more bioactive and bonds to soft tissue, whereas S53P4 is often preferred for specific cranial applications or where a slower dissolution rate is desired. The choice depends on the specific clinical requirement.

Why Partner with Jinan Meiyi Biotechnology?

In the competitive landscape of medical device and aesthetic product manufacturing, the reliability of your supply chain is as important as the quality of your product. Partnering with Jinan Meiyi Biotechnology Co., Ltd. offers several strategic advantages rooted in scientific rigor and market responsiveness.

Consistency and Reproducibility: Medical regulations demand batch-to-batch consistency. Our controlled sourcing and quality verification processes ensure that every gram of glass performs identically, reducing variability in your final device and simplifying your quality control processes.

Regulatory Confidence: Our documentation and quality systems are designed to support your regulatory submissions. We understand the requirements of FDA, EU MDR, and other global health authorities, providing the transparency and data needed for faster approvals.

Technical Expertise: We are not just suppliers; we are partners in innovation. Our team of materials scientists and engineers, with deep specialization in bioactive technology applications, can provide technical support during your R&D phase, helping you optimize formulations and solve processing challenges.

Scalability and Global Reach: Whether you are in the prototype stage or ramping up for mass production, our global supply chain network can scale to meet your needs. We serve clients across Asia, Europe, and North America, ensuring a secure supply of raw materials and preventing production delays.

Conclusion and Next Steps

Synthetic 45S5 Bioactive Glass remains the benchmark for bioactive materials in regenerative medicine. Its proven ability to bond with bone and soft tissue, combined with its osteostimulative and antibacterial properties, makes it an indispensable component in modern medical devices. By choosing a partner like Jinan Meiyi Biotechnology, you secure not only a high-quality raw material but also a partnership grounded in expertise, reliability, and regulatory compliance.

For medical device companies, research institutions, and distributors, the choice of supplier is a critical decision. Ensure your partner can deliver the purity, consistency, and documentation required for success in the global healthcare market.

Ready to optimize your product formulation?

Contact our technical sales team today to request samples, review detailed specification sheets, or discuss custom manufacturing solutions for your specific application. Let us support your innovation with premium, ISO-certified Synthetic 45S5 Bioactive Glass.

Explore our full range of bioactive materials and technical resources